|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,275.00 JPY | -1.16% |
|
+15.07% | -29.10% |
| 02-19 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
Company Valuation: Cuorips Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 29,126 | 67,173 |
| Change | - | 130.63% |
| Enterprise Value (EV) 1 | 23,544 | 62,380 |
| Change | - | 164.96% |
| P/E | -43x | -103x |
| PBR | 4.91x | 12.2x |
| PEG | - | 16.48x |
| Capitalization / Revenue | 1,266x | 384x |
| EV / Revenue | 1,024x | 356x |
| EV / EBITDA | -45.5x | -121x |
| EV / EBIT | -40x | -106x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -85.84 | -80.48 |
| Distribution rate | - | - |
| Net sales 1 | 23 | 175 |
| EBITDA 1 | -518 | -514 |
| EBIT 1 | -588 | -590 |
| Net income 1 | -632 | -644 |
| Net Debt 1 | -5,582 | -4,793 |
| Reference price 2 | 3,695.00 | 8,310.00 |
| Nbr of stocks (in thousands) | 7,882 | 8,083 |
| Announcement Date | 6/27/24 | 6/20/25 |
1JPY in Million2JPY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 220M | ||
| 16.14x | 3.5x | 9.43x | 0.63% | 63.44B | ||
| 28.16x | 5.74x | 16.78x | 0.56% | 56.98B | ||
| 34.47x | 11.67x | 22.1x | -.--% | 41.58B | ||
| -42.72x | 3.04x | 9x | 3.59% | 38.01B | ||
| 34.89x | 3.71x | 11.39x | -.--% | 31.9B | ||
| -8.11x | 11.55x | -7.09x | -.--% | 27.79B | ||
| 16.45x | 3.12x | 9.45x | -.--% | 22.65B | ||
| 50.09x | 5.51x | 38.17x | -.--% | 17.64B | ||
| 25.55x | 5.31x | 14.24x | -.--% | 16.49B | ||
| Average | 17.21x | 5.91x | 13.72x | 0.53% | 31.67B | |
| Weighted average by Cap. | 15.81x | 5.83x | 12.97x | 0.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4894 Stock
- Valuation Cuorips Inc.
Select your edition
All financial news and data tailored to specific country editions
















